MicroRNAs As a Tool for Differential Diagnosis of Neuromuscular Disorders

Overview

Journal Neuromolecular Med

Specialty Biochemistry

Date 2023 Oct 19

PMID 37856057

Authors

Nahla O Mousa

Ahmed Abdellatif

Nagia Fahmy

Hassan El-Fawal

Ahmed Osman

Affiliations

Soon will be listed here.

Abstract

Neuromuscular disorders (NMD) are a class of progressive disorders that are characterized by wasting of the muscles. Some of the disorders like Duchenne muscular dystrophy (DMD), Becker muscular dystrophy (BMD), congenital muscular dystrophies (CMDs), limb-girdle muscular dystrophies (LGMD), and mild spinal muscular atrophy (SMA) type III share several presenting clinical features, and hence, diagnosis is usually a challenging task. In this study, the diagnostic potential of some species of microRNAs (miRNAs) that are known to play roles in normal and pathological contexts of myocytes (myomiRs) were evaluated to assess their potential in differential diagnosis of NMDs. In this study, seventy-four patients with different neuromuscular disorders along with thirty age-matched healthy control subjects were enrolled. Peripheral blood samples were collected from enrolled subjects followed by miRNA extraction and reverse transcription followed by quantification of the circulating levels of the studied miRNAs (miR-499, miR-206, miR-208a, miR-223, miR-191, miR-103a-3p, miR-103a-5p), by real-time PCR and statistical analysis. The data indicated that miR-499 level showed high circulating levels in DMD patients as well as in patients with other related disorders such as BMD. However, the levels of miR-499 were much higher in DMD patients and it can be used to diagnose DMD. In addition, miR-206 can selectively differentiate between DMD and all other disorders. The results also revealed that miR-208a and miR-223 were significantly dysregulated in SMA patients, and miR-103a-3p could distinguish DMD from BMD. The expression levels of some miRNA species can be utilized in the process of differential diagnosis of NMDs and can serve as a diagnostic biomarker, and such findings will pave the way towards generating targeted therapies.

References

DAmico A, Mercuri E, Tiziano F, Bertini E . Spinal muscular atrophy. Orphanet J Rare Dis. 2011; 6:71. PMC: 3231874. DOI: 10.1186/1750-1172-6-71. View

Hawley Z, Campos-Melo D, Droppelmann C, Strong M . MotomiRs: miRNAs in Motor Neuron Function and Disease. Front Mol Neurosci. 2017; 10:127. PMC: 5415563. DOI: 10.3389/fnmol.2017.00127. View

Hoye M, Koval E, Wegener A, Hyman T, Yang C, OBrien D . MicroRNA Profiling Reveals Marker of Motor Neuron Disease in ALS Models. J Neurosci. 2017; 37(22):5574-5586. PMC: 5452343. DOI: 10.1523/JNEUROSCI.3582-16.2017. View

Matsuzaka Y, Kishi S, Aoki Y, Komaki H, Oya Y, Takeda S . Three novel serum biomarkers, miR-1, miR-133a, and miR-206 for Limb-girdle muscular dystrophy, Facioscapulohumeral muscular dystrophy, and Becker muscular dystrophy. Environ Health Prev Med. 2014; 19(6):452-8. PMC: 4235845. DOI: 10.1007/s12199-014-0405-7. View

Wu J, Yue B, Lan X, Wang Y, Fang X, Ma Y . MiR-499 regulates myoblast proliferation and differentiation by targeting transforming growth factor β receptor 1. J Cell Physiol. 2018; 234(3):2523-2536. DOI: 10.1002/jcp.26903. View

Kolb S, Kissel J . Spinal Muscular Atrophy. Neurol Clin. 2015; 33(4):831-46. PMC: 4628728. DOI: 10.1016/j.ncl.2015.07.004. View

Awasthi K, Arya R, Bhattacharya A, Bhattacharya S . The Inherited Neuromuscular Disorder GNE Myopathy: Research to Patient Care. Neurol India. 2019; 67(5):1213-1219. DOI: 10.4103/0028-3886.271259. View

Shyu K, Wang B, Cheng W, Lo H . MicroRNA-208a Increases Myocardial Endoglin Expression and Myocardial Fibrosis in Acute Myocardial Infarction. Can J Cardiol. 2015; 31(5):679-90. DOI: 10.1016/j.cjca.2014.12.026. View

Meng Q, Lan D . [A review on muscle-specific microRNAs as the biomarker for Duchenne muscular dystrophy]. Zhongguo Dang Dai Er Ke Za Zhi. 2019; 21(11):1148-1152. PMC: 7389306. View

10.

Rybalka E, Timpani C, Cooke M, Williams A, Hayes A . Defects in mitochondrial ATP synthesis in dystrophin-deficient mdx skeletal muscles may be caused by complex I insufficiency. PLoS One. 2014; 9(12):e115763. PMC: 4277356. DOI: 10.1371/journal.pone.0115763. View

11.

Koutsoulidou A, Koutalianos D, Georgiou K, Kakouri A, Oulas A, Tomazou M . Serum miRNAs as biomarkers for the rare types of muscular dystrophy. Neuromuscul Disord. 2022; 32(4):332-346. DOI: 10.1016/j.nmd.2022.03.003. View

12.

Xiao J, Shen B, Li J, Lv D, Zhao Y, Wang F . Serum microRNA-499 and microRNA-208a as biomarkers of acute myocardial infarction. Int J Clin Exp Med. 2014; 7(1):136-41. PMC: 3902251. View

13.

Coenen-Stass A, Wood M, Roberts T . Biomarker Potential of Extracellular miRNAs in Duchenne Muscular Dystrophy. Trends Mol Med. 2017; 23(11):989-1001. DOI: 10.1016/j.molmed.2017.09.002. View

14.

Simone C, Ramirez A, Bucchia M, Rinchetti P, Rideout H, Papadimitriou D . Is spinal muscular atrophy a disease of the motor neurons only: pathogenesis and therapeutic implications?. Cell Mol Life Sci. 2015; 73(5):1003-20. PMC: 4756905. DOI: 10.1007/s00018-015-2106-9. View

15.

Nowak K, Davies K . Duchenne muscular dystrophy and dystrophin: pathogenesis and opportunities for treatment. EMBO Rep. 2004; 5(9):872-6. PMC: 1299132. DOI: 10.1038/sj.embor.7400221. View

16.

Cacchiarelli D, Martone J, Girardi E, Cesana M, Incitti T, Morlando M . MicroRNAs involved in molecular circuitries relevant for the Duchenne muscular dystrophy pathogenesis are controlled by the dystrophin/nNOS pathway. Cell Metab. 2010; 12(4):341-351. DOI: 10.1016/j.cmet.2010.07.008. View

17.

Freund A, Scola R, Arndt R, Lorenzoni P, Kay C, Werneck L . Duchenne and Becker muscular dystrophy: a molecular and immunohistochemical approach. Arq Neuropsiquiatr. 2007; 65(1):73-6. DOI: 10.1590/s0004-282x2007000100016. View

18.

Wang L, Zhang V, Li S, Li H, Sun Y, Li J . The clinical spectrum and genetic variability of limb-girdle muscular dystrophy in a cohort of Chinese patients. Orphanet J Rare Dis. 2018; 13(1):133. PMC: 6092860. DOI: 10.1186/s13023-018-0859-6. View

19.

McNally E, Pytel P . Muscle diseases: the muscular dystrophies. Annu Rev Pathol. 2007; 2:87-109. DOI: 10.1146/annurev.pathol.2.010506.091936. View

20.

Rizzuti M, Filosa G, Melzi V, Calandriello L, Dioni L, Bollati V . MicroRNA expression analysis identifies a subset of downregulated miRNAs in ALS motor neuron progenitors. Sci Rep. 2018; 8(1):10105. PMC: 6031650. DOI: 10.1038/s41598-018-28366-1. View